Terns Pharmaceuticals, Inc. Common Stock
XNAS:TERN
35.31
$40.00 - 5.00
$34.36 - 10.00
$34.26
$36.46
$35.91
$35.97
48.26
1.87
2171150
2313906
92077101.48
Chart
TendieTensor AI Analysis
Company
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Fundamentals
59
-33.270000
10.576000
100
BBG00KK1SJ08
BBG00KK1SJ17
87.51M
87.51M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own TERN. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.